Literature DB >> 19834632

From asthma severity to control: a shift in clinical practice.

Søren Pedersen1.   

Abstract

Variability is a characteristic feature of asthma, and the aim of asthma management is to eliminate or minimise disease variability. Controlled asthma shows little or no variability, and is achievable and sustainable in the majority of patients. New international guidelines recommend control-driven management rather than management based on disease severity. Good asthma control is associated with reductions in patients' perception of the asthma burden, reduced healthcare resource utilisation, lower levels of impairment/restriction, normal quality of life, and low risk of exacerbations. Asthma control involves the control of several outcomes. Its assessment should include components relevant to achievement of best possible clinical control and reduction of future risk of adverse outcomes. Focusing on a single or a few outcomes can lead to incorrect control assessment and increased risk of under-treatment. Several validated asthma control assessment tools have been developed to facilitate correct assessment of the level of control in clinical practice. It is hoped that focusing on control will reduce the frequency of sub-optimal treatment in the primary care setting. Further validation of the best way to assess control easily and accurately, and the implementation of control-driven management, are the two most important challenges for the future of asthma management.

Entities:  

Mesh:

Year:  2010        PMID: 19834632      PMCID: PMC6827613          DOI: 10.4104/pcrj.2009.00059

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  9 in total

1.  Cost considerations of therapeutic options for children with asthma.

Authors:  Sandra Chuang; Adam Jaffe
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

2.  [Influencing factors and evaluation indicators for asthma control level in children].

Authors:  Li Tan; Quan Zhang; Cheng-Qing Wu; Ji Wang; Ming Li; Dong-Mei Ye; Lin Wang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2016-09

3.  Is Clinical Judgment of Asthma Control Adequate?: A prospective survey in a tertiary hospital pulmonary clinic.

Authors:  Sawsan Baddar; B Jayakrishnan; Omar Al-Rawas; Jojy George; Khalfan Al-Zeedy
Journal:  Sultan Qaboos Univ Med J       Date:  2013-02-27

4.  Uncontrolled asthma: assessing quality of life and productivity of children and their caregivers using a cross-sectional Internet-based survey.

Authors:  Bonnie B Dean; Brian C Calimlim; Patricia Sacco; Daniel Aguilar; Robert Maykut; David Tinkelman
Journal:  Health Qual Life Outcomes       Date:  2010-09-08       Impact factor: 3.186

5.  Infection with Mycoplasma pneumoniae is not related to asthma control, asthma severity, and location of airway obstruction.

Authors:  Khalil Ansarin; Siavoush Abedi; Reza Ghotaslou; Mohammad Hossein Soroush; Kamyar Ghabili; Kenneth R Chapman
Journal:  Int J Gen Med       Date:  2010-12-20

6.  Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to Symptoms and Experience (REALISE) survey.

Authors:  David Price; Monica Fletcher; Thys van der Molen
Journal:  NPJ Prim Care Respir Med       Date:  2014-06-12       Impact factor: 2.871

Review 7.  Failure in asthma control: reasons and consequences.

Authors:  Fulvio Braido
Journal:  Scientifica (Cairo)       Date:  2013-12-18

8.  Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.

Authors:  Jean Bousquet; Neil Barnes; Michael Gibbs; Nadeem Gul; Susan A Tomkins; Xin Zhou; Young-Joo Cho; Hae-Sim Park; William Busse; Nanshan Zhong
Journal:  BMC Pulm Med       Date:  2017-04-28       Impact factor: 3.317

9.  Management of Asthma Exacerbations in Southeast Asian Tertiary Care.

Authors:  Mau-Ern Poh; Sundari Ampikaipakan; Chong-Kin Liam; Chee-Shee Chai; Deventhari Ramanaidoo; Helmy Haja Mydin
Journal:  J Asthma Allergy       Date:  2021-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.